Response to Intravenous Glucose-Tolerance Test and Risk of Cancer: A Long-Term Prospective Cohort Study

Overview

Journal EBioMedicine

Specialty Biomedical Engineering

Date 2017 Jul 9

PMID 28687499

Citations 5

Authors

R S Falk

S Tretli

J E Paulsen

L Sandvik

J Erikssen

T Heir

Affiliations

Soon will be listed here.

Abstract

Background: Impaired glucose regulation, measured with an oral glucose-tolerance test, has been associated with the risk of cancer. Here, we explored whether the response to an intravenous glucose-tolerance test (IVGTT) is associated with the risk of cancer.

Methods: A cohort of 945 healthy men, aged 40-59years in 1972-75, was followed for 40years. An IVGTT was performed at baseline. Blood samples for glucose determinations were drawn immediately before glucose injection and thereafter every 10min for 1h. Associations were assessed with incidence rate ratios (IRR) and Cox models.

Findings: Cancer incidence was higher among men with 10-min glucose levels below the median than in men with levels above the median (IRR: 1.5, 95% CI: 1.2-1.9). This association remained significant after adjusting for relevant confounders (HR: 1.6, 95% CI: 1.3-2.1) and when excluding the first 10years of follow-up to minimize the possibility of reverse causality (HR: 1.5, 95% CI: 1.2-2.0).

Interpretation: Healthy middle-aged males that responded to an intravenous glucose injection with rapid glucose elimination during the first phase had an elevated risk of cancer during 40years of follow-up. First phase response to a glucose load might be related to cancer development.

Citing Articles

The Oslo Ischaemia Study: cohort profile.

Falk R, Mariampillai J, Prestgaard E, Heir T, Bodegard J, Robsahm T BMJ Open. 2021; 11(10):e049111.

PMID: 34645662 PMC: 8515426. DOI: 10.1136/bmjopen-2021-049111.

Glucose Intolerance and Cancer Risk: A Community-Based Prospective Cohort Study in Shanghai, China.

Ke J, Lin T, Liu X, Wu K, Ruan X, Ding Y Front Oncol. 2021; 11:726672.

PMID: 34527591 PMC: 8435720. DOI: 10.3389/fonc.2021.726672.

Fasting Serum Levels of Potassium and Sodium in Relation to Long-Term Risk of Cancer in Healthy Men.

Falk R, Heir T, Robsahm T, Tretli S, Sandvik L, Erikssen J Clin Epidemiol. 2020; 12:1-8.

PMID: 32021466 PMC: 6959139. DOI: 10.2147/CLEP.S216438.

Changes in midlife fitness, body mass index, and smoking influence cancer incidence and mortality: A prospective cohort study in men.

Robsahm T, Heir T, Sandvik L, Prestgaard E, Tretli S, Erikssen J Cancer Med. 2019; 8(10):4875-4882.

PMID: 31270954 PMC: 6712445. DOI: 10.1002/cam4.2383.

Is there an Association between ß-Cell Function and Cancer Risk?.

Hodge A EBioMedicine. 2017; 22:24-25.

PMID: 28711482 PMC: 5552204. DOI: 10.1016/j.ebiom.2017.07.006.

References

Page T, Hodgkinson A, Ollerenshaw M, Hammonds J, Demaine A . Glucose transporter polymorphisms are associated with clear-cell renal carcinoma. Cancer Genet Cytogenet. 2005; 163(2):151-5. DOI: 10.1016/j.cancergencyto.2005.07.004. View

Erikssen J, ENGER S . Intravenous glucose tolerance test in middle-aged men with and without latent coronary heart disease. Acta Med Scand. 1977; 202(5):357-62. DOI: 10.1111/j.0954-6820.1977.tb16843.x. View

Zhou X, Qiao Q, Zethelius B, Pyorala K, Soderberg S, Pajak A . Diabetes, prediabetes and cancer mortality. Diabetologia. 2010; 53(9):1867-76. DOI: 10.1007/s00125-010-1796-7. View

Bjornholt J, Erikssen G, Liestol K, JERVELL J, Erikssen J, Thaulow E . Prediction of Type 2 diabetes in healthy middle-aged men with special emphasis on glucose homeostasis. Results from 22.5 years' follow-up. Diabet Med. 2001; 18(4):261-7. DOI: 10.1046/j.1464-5491.2001.00488.x. View

Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G . Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia. 2006; 49(5):945-52. DOI: 10.1007/s00125-006-0207-6. View

Barron C, Bilan P, Tsakiridis T, Tsiani E . Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment. Metabolism. 2016; 65(2):124-39. DOI: 10.1016/j.metabol.2015.10.007. View

Fan R, Hou W, Zhao Y, Liu S, Qiu X, Wang E . Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells. Tumour Biol. 2015; 37(4):4655-63. DOI: 10.1007/s13277-015-4221-5. View

Jang M, Kim S, Lee J . Cancer cell metabolism: implications for therapeutic targets. Exp Mol Med. 2013; 45:e45. PMC: 3809361. DOI: 10.1038/emm.2013.85. View

Heir T, Erikssen J, Sandvik L . Overweight as predictor of long-term mortality among healthy, middle-aged men: a prospective cohort study. Prev Med. 2011; 52(3-4):223-6. DOI: 10.1016/j.ypmed.2011.01.010. View

10.

LEVINE W, Dyer A, SHEKELLE R, SCHOENBERGER J, Stamler J . Post-load plasma glucose and cancer mortality in middle-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am J Epidemiol. 1990; 131(2):254-62. DOI: 10.1093/oxfordjournals.aje.a115495. View

11.

Larsen I, Smastuen M, Johannesen T, Langmark F, Parkin D, Bray F . Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2008; 45(7):1218-1231. DOI: 10.1016/j.ejca.2008.10.037. View

12.

Jee S, Ohrr H, Sull J, Yun J, Ji M, Samet J . Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005; 293(2):194-202. DOI: 10.1001/jama.293.2.194. View

13.

Heir T, Falk R, Robsahm T, Sandvik L, Erikssen J, Tretli S . Cholesterol and prostate cancer risk: a long-term prospective cohort study. BMC Cancer. 2016; 16:643. PMC: 4989293. DOI: 10.1186/s12885-016-2691-5. View

14.

Hirakawa Y, Ninomiya T, Mukai N, Doi Y, Hata J, Fukuhara M . Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study. Am J Epidemiol. 2012; 176(10):856-64. DOI: 10.1093/aje/kws178. View

15.

Amann T, Kirovski G, Bosserhoff A, Hellerbrand C . Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma. Mol Membr Biol. 2011; 28(3):182-6. DOI: 10.3109/09687688.2011.554447. View

16.

Erikssen G, Liestol K, Bjornholt J, Thaulow E, Sandvik L, Erikssen J . Changes in physical fitness and changes in mortality. Lancet. 1998; 352(9130):759-62. DOI: 10.1016/S0140-6736(98)02268-5. View

17.

Huang Y, Cai X, Qiu M, Chen P, Tang H, Hu Y . Prediabetes and the risk of cancer: a meta-analysis. Diabetologia. 2014; 57(11):2261-9. DOI: 10.1007/s00125-014-3361-2. View

18.

Saydah S, Loria C, Eberhardt M, Brancati F . Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol. 2003; 157(12):1092-100. DOI: 10.1093/aje/kwg100. View

19.

Grundvold I, Skretteberg P, Liestol K, Erikssen G, Kjeldsen S, Arnesen H . Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study. Hypertension. 2012; 59(2):198-204. DOI: 10.1161/HYPERTENSIONAHA.111.179713. View